Glycopyrrolate Injection
Product Images NDC 71872-7012

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (20ml Vial)

Glycopyrrolate Injection is a USP approved medication that needs to be stored between 20 to 25°C. The manufacturer of this medication is Antrovenns and it is mostly sold in Somerset 2.*

FDA Label Image

Molecular Structure (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 01)

FDA Label Image

Pdp (7012)

This is a description of glycopyrrolate injection, a medication administered intramuscularly or intravenously indicated for certain medical situations. It is available in a 4mg/20 mL (0.2 mg/mL) 20 mL multiple-dose vial containing benzyl alcohol as preservative. However, it is not for use in newborns. The drug should be stored at a temperature range of 201-25°C (88-77°F). The usual dosage is specified in the package insert. The drug is manufactured by Wirtas Limited in India, for Somerset Therapeutics, LLC located in New Jersey, USA. The medication is also distributed by Medical Purchasing Solutions located in Scottsdale, AZ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.